Experience with prazosin in the treatment of patients with severe hypertension.

Abstract

The efficacy and safety of prazosin, a new vasodilator antihypertensive agent, used mainly in combination with other hypotensive medication, was evaluated in 50 hypertensive patients, 28 of whom had left ventricular hypertrophy and 28 of whom had renal impairment. In 44 cases this agent was introduced because of an inadequate response to, or side effects… (More)

Topics

  • Presentations referencing similar topics